Research Status and Suggestion of Drug Clinical Trial Risk Management in China: Based on Co-word Analysis and Social Network Analysis Perspective / 中国医学伦理学
Chinese Medical Ethics
; (6): 271-276, 2023.
Article
en Zh
| WPRIM
| ID: wpr-1005543
Biblioteca responsable:
WPRO
ABSTRACT
【Objective:】 To deeply understand the current situation and hotspots of drug clinical trials risk management in China. 【Methods:】 Co-word analysis and social network analysis were used to sort out the study results of risk management in drug clinical trials in China. 【Results:】 The trend of risk research of drug clinical trials in China was generally on the rise. The research hotspots focused on four areas: drug supervision and pharmacovigilance, risk management of drug clinical trial institutions, ethical review of drug clinical trials, and risk management of drug clinical trials. 【Conclusion:】 In the future, China should gradually improve the risk management system and supervision system of drug clinical trials, explore to establish a risk-based quality management and ethical review system of drug clinical trials, and enhance the risk assessment and coping ability of institutions.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Chinese Medical Ethics
Año:
2023
Tipo del documento:
Article